Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 20, 2011
Lysophosphatidic acid is a modulator of cyst growth in autosomal dominant polycystic kidney diseaseBonnie L Blazer-Yost, Brenda J Blacklock, Stephanie Flaig, et al.
Cell|October 20, 1998
G protein signaling events are activated at the leading edge of chemotactic cellsC A Parent, B J Blacklock, W M Froehlich, et al.
Lancet (London, England)|August 20, 1983
Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanismsS R Ahmed, P J Brooman, S M Shalet, et al.
British Journal of Urology|August 1, 1986
Does sucrose damage kidneys?M K Li, J P Kavanagh, V Prendiville, et al.
Clinical Science (London, England : 1979)|April 1, 1986
Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophyH Gregory, I R Willshire, J P Kavanagh, et al.
British Journal of Urology|June 1, 1987
Radiation dose to patient and staff during percutaneous nephrostolithotomyP N Rao, K Faulkner, J K Sweeney, et al.
British Medical Journal (Clinical Research Ed.)|January 19, 1985
Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancerS R Ahmed, J Grant, S M Shalet, et al.
British Journal of Urology|October 1, 1986
A new hormonal therapy for prostatic cancer: long-term clinical and hormonal responseS R Ahmed, J B Grant, S M Shalet, et al.
Pageof 8